Pillstats
Rx only · Tablet, Extended Release · Oral

Fluvastatin Sodium

Brands: Lescol Xl · Fluvastatin Sodium

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC10AA04
RxCUI (US)41127
US makers1 labelers
Packages3
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.75$3.49$5.24$6.98Dec 2025Apr 2026Jul 2026
$6.060
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/an/a81624322025 Q12025 Q22025 Q32025 Q42026 Q1
28
Rx · 2025 Q3
1.9K
Units dispensed
3
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Sandoz Incunknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 27, 2026
    RESOLVEDShortage resolved: Fluvastatin Sodium Tablet, Extended Release (Sandoz Inc.)

    Fluvastatin Sodium Tablet, Extended Release — reported in shortage by Sandoz Inc.. Therapeutic category: Cardiovascular.

  • Jan 27, 2026
    SHORTAGEDrug shortage: Fluvastatin Sodium Tablet, Extended Release (Sandoz Inc.)

    Fluvastatin Sodium Tablet, Extended Release — reported in shortage by Sandoz Inc.. Therapeutic category: Cardiovascular.